WebNews
Please enter a web search for web results.
NewsWeb
Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefits in Wilson's Disease
1+ week, 10+ hour ago (120+ words) The publication is available online at: Advances in Redox Research Publication According to the publication, Telomir-Zn demonstrated improvements across cellular and in vivo endpoints in the Wilson's disease model, including: Preservation of metabolic viability under copper and peroxide challenge Reduction…...
Which Over-the-Counter CGM Should You Buy? Breaking Down Differences Between Stelo, Lingo and Levels
7+ hour, 37+ min ago (250+ words) For decades, watching your blood sugar move in real time required a prescription, a finger prick or both. That barrier is gone." Stelo, Lingo and Levels are now available to adults who want to see how food, sleep, stress and…...
Google Health's rough Fitbit takeover is already forcing a major cleanup plan
11+ hour, 50+ min ago (690+ words) Google is moving to calm frustration around its redesigned Google Health app, which has replaced Fitbit and is now available to Android and i OS users as version 5. 0. The first repair is basic but important. Runs that appeared as general…...
Abbott wins CE mark for dual glucose-ketone sensor
9+ hour, 58+ min ago (280+ words) May 27, 2026 By Sean Whooley The company said its dual sensor marks a world first, continuously measuring glucose and ketone levels every minute. Branded as Libre Duo and Libre Duo 10 Day, the sensors provide real-time visibility into glucose levels as a…...
Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes
10+ hour, 4+ min ago (437+ words) May 27, 2026, 09: 00 ET This CE Mark covers two Libre Duo systems. Libre Duo delivers up to 15 days of wear and will be offered to adults ages 18 and older. Libre Duo 10 Day offers up to 10 days of wear and is intended for…...
Signos grows foothold in weight-loss wave fueled by GLP-1s with its AI health data tracking
9+ hour, 52+ min ago (453+ words) Health tech startup Signos announced a $20 million funding round on Wednesday, growing its foothold in the GLP-1-fueled weight loss market and expanding its partnership with medical device giant Dexcom. Google Ventures, Dexcom and Blue Cross Blue Shield of Alabama…...
Signos grows foothold in weight loss wave fueled by GLP-1s with its AI health data tracking
7+ hour, 26+ min ago (454+ words) Health technology startup Signos announced a $20 million funding round on Wednesday, growing its foothold in the GLP-1-fueled weight loss market and expanding its partnership with medical device giant Dexcom. Google Ventures, Dexcom and Blue Cross Blue Shield of Alabama…...
50 take advantage of free sports physicals, heart screenings
16+ hour, 4+ min ago (279+ words) To purchase a new subscription or to validate your current account for free online access, please click Continue below. Care teams from Advent Health and Who We Play offered sports physicals and ECG heart screenings, supporting both students" health and…...
Glucotrack CEO explains tech behind long-term CBGM implant
12+ hour, 4+ min ago (599+ words) May 27, 2026 By Sean Whooley Glucotrack (Nasdaq: GCTK) has made great strides over the past several years as it advances its implantable continuous blood glucose monitor (CBGM). After the company completed the first-in-human study'of the system, it shared findings from that…...
Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions
12+ hour, 4+ min ago (385+ words) Press release " No. 10 / 2026 Zealand Pharma to Present Data atthe American Diabetes Association's 2026 Scientific Sessions Late-breaking Phase 2 ZUPREME-1 data on petrelintide to be featured as e Poster Theater presentation and poster sessions "The ADA's Scientific Sessions is one of the most…...